avigation
olchemim LABELLED BRASSINOSTEROIDS
發布時間：2024-06-13
訪問次數：1849
公司地址：廣州市天河區天河北路僑林街47號中旅商務大廈東塔25E
產品價格：來電咨詢
[2H3]BRASSINOLIDE(D-BI) [[26-2H3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestan-6-one]
| MW 483.71; crystalline; purity > 95% (HPLC) | ||
| S:26, 36; CAS: 461670-12-2; C28H452H3O6 | ||
 | ||
| 038 5891 | 100 | µg |
| 038 5892 | 200 | µg |
| 038 5893 | 500 | µg |
[2H3]EPIBRASSINOLIDE(D-EBI) [[2H3]24-epibrassinolide, [26-2H3],(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one]
| MW 483.67; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: 1316216-51-9; C28H452H3O6 | ||
 | ||
| 038 0201 | 100 | µg |
| 038 0202 | 200 | µg |
| 038 0203 | 500 | µg |
[2H3]BRASSINONE (D-NBk) [[2H3] 28-norcastasterone, [26-2H3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-5α-cholestan-6-one]
| MW 453.64; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: NONE; C27H432H3O5 | ||
 | ||
| 038 5631 | 100 | µg |
| 038 5632 | 200 | µg |
| 038 5633 | 500 | µg |
[2H3]CASTASTERONE(D-Bk) [[26-2H3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestan-6-one]
| MW 467.71; crystalline; purity > 94% (HPLC) | ||
| S:26, 36; CAS: 461670-13-3; C28H452H3O5 | ||
 | ||
| 038 6651 | 100 | µg |
| 038 6652 | 200 | µg |
| 038 6653 | 500 | µg |
[2H3]EPICASTASTERONE (D-EBk) [[2H3] 24-epicastasterone, [26-2H3] (22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
| MW 467.67; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: 1316216-47-3; C28H452H3O5 | ||
 | ||
| 038 0901 | 100 | µg |
| 038 0902 | 200 | µg |
| 038 0903 | 500 | µg |
[2H3]CAMPESTANOL (D-CAMP) [[26-2H3](24R)-3-β-hydroxy-24-methyl-5α-cholestane]
| MW 405.69; crystalline; purity > 90% ( HPLC ) | ||
| S:26, 36; CAS: N/A; C28H472H3O | ||
 | ||
| 038 6781 | 100 | µg |
| 038 6782 | 200 | µg |
| 038 6783 | 500 | µg |
[2H3]CATHASTERONE (D-CATH) [[22,26,26-2H3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane-6-one]
| MW 435.67; crystalline; purity > 95% ( HPLC ) | ||
| S:26, 36; CAS: N/A; C28H452H3O3 | ||
 | ||
| 038 6761 | 100 | µg |
| 038 6762 | 200 | µg |
| 038 6763 | 500 | µg |
[2H3]6-DEOXO-24-EPICASTASTERONE (D-EBd) [[26-2H3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane]
| MW 453.68, crystalline; purity >98% (HPLC) | ||
| S:26, 36; CAS: N/A; C28H472H3O4 | ||
 | ||
| 038 0921 | 100 | µg |
| 038 0922 | 200 | µg |
| 038 0923 | 500 | µg |
[2H3]6-DEOXOCASTASTERONE (D-6deoxoCS) [[26-2H3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane
| MW 453.68, crystalline; purity >98% (HPLC) | ||
| S:26, 36; CAS: N/A; C28H472H3O4 | ||
 | ||
| 038 7511 | 100 | µg |
| 038 7512 | 200 | µg |
| 038 7513 | 500 | µg |
[2H3]6-DEOXYTYPHASTEROL (D-DECATH) [[26-2H3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane]
| MW 421.69; crystalline; purity > 98% ( HPLC ) | ||
| S:26, 36; CAS: 1449510-51-3; C28H472H3O2 | ||
 | ||
| 038 6771 | 100 | µg |
| 038 6772 | 200 | µg |
| 038 6773 | 500 | µg |
[2H3]CAMPESTEROL (D-CR) [[26-2H3](3S,8S,9S10R14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopentaphenanthren-3-ol]
| MW 403.67; crystalline; purity > 98% ( HPLC ) | ||
| S:26, 36; CAS: N/A; C28H482H3O | ||
 | ||
| 038 6921 | 100 | µg |
| 038 6922 | 200 | µg |
| 038 6923 | 500 | µg |
[2H3]NORBRASSINOLIDE (D-NBI) [[2H3] 28-norbrassinolide, [26-2H3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-B-homo-7-oxa-5α-cholestan-6-one]
| MW 469.64; crystalline; purity > 98% (HPLC) | ||
| S:26, 36; CAS: NONE; C27H432H3O6 | ||
 | ||
| 038 5621 | 100 | µg |
| 038 5622 | 200 | µg |
| 038 5623 | 500 | µg |
[2H3]TYPHASTEROL (D-TY) [[26-2H3] 3,22,23-trihydroxy-(3α,5α,22R,23R,24S)-Ergostan-6-one]
| MW 451.67; crystalline; purity > 90% (HPLC) | ||
| S:26, 36; CAS: 461670-14-4; C28H452H3O4 | ||
 | ||
| 038 7161 | 100 | µg |
| 038 7162 | 200 | µg |
| 038 7163 | 500 | µg |